These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 19485912)
1. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912 [TBL] [Abstract][Full Text] [Related]
2. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Begbie ME; Wallace GM; Shovlin CL Postgrad Med J; 2003 Jan; 79(927):18-24. PubMed ID: 12566546 [TBL] [Abstract][Full Text] [Related]
3. How to manage patients with hereditary haemorrhagic telangiectasia. Geisthoff UW; Nguyen HL; Röth A; Seyfert U Br J Haematol; 2015 Nov; 171(4):443-52. PubMed ID: 26205234 [TBL] [Abstract][Full Text] [Related]
4. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role. Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660 [TBL] [Abstract][Full Text] [Related]
5. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review. Harrison L; Kundra A; Jervis P J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780 [TBL] [Abstract][Full Text] [Related]
6. Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience. Morais D; Millás T; Zarrabeitia R; Botella LM; Almaraz A Rhinology; 2012 Mar; 50(1):80-6. PubMed ID: 22469609 [TBL] [Abstract][Full Text] [Related]
7. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding. Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636 [TBL] [Abstract][Full Text] [Related]
8. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells. Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064 [TBL] [Abstract][Full Text] [Related]
9. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review. Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079 [TBL] [Abstract][Full Text] [Related]
10. Medical management of haemorrhagic hereditary telangiectasia in adult patients. Riera-Mestre A; Ribas J; Castellote J Med Clin (Barc); 2019 Apr; 152(7):274-280. PubMed ID: 30502301 [TBL] [Abstract][Full Text] [Related]
11. Rendu-Osler-Weber disease: experience with 56 patients. Sabbà C; Pasculli G; Cirulli A; Gallitelli M; Virgilio G; Guastamacchia E; Resta F; Palasciano G Ann Ital Med Int; 2002; 17(3):173-9. PubMed ID: 12402665 [TBL] [Abstract][Full Text] [Related]
12. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Stuhrmann M; El-Harith el-HA Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283 [TBL] [Abstract][Full Text] [Related]
14. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu). Hanks JE; Hunter D; Goding GS; Boyer HC Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220 [TBL] [Abstract][Full Text] [Related]